Efficacy and safety of midazolam and oxazepam in insomniacs. 1983

R Lupolover, and U Ballmer, and J Helcl, and J Escher, and B Pavletic

In a multicentre, double-blind, parallel study performed in 78 hospitalized patients who complained of mild, moderate or severe insomnia, the efficacy and safety of 15 mg midazolam were compared with those of 15 mg oxazepam, both orally administered. The results showed statistically significant better results in the onset of sleep in the patients treated with midazolam. Other sleep parameters, such as quality and duration of sleep as well as the condition of the patients on morning awakenings, were also improved in more patients treated with midazolam. Safety (clinical and biological) was very good in both groups of patients.

UI MeSH Term Description Entries
D007319 Sleep Initiation and Maintenance Disorders Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition. Disorders of Initiating and Maintaining Sleep,Insomnia,Sleeplessness,Chronic Insomnia,DIMS (Disorders of Initiating and Maintaining Sleep),Early Awakening,Insomnia Disorder,Nonorganic Insomnia,Primary Insomnia,Psychophysiological Insomnia,Rebound Insomnia,Secondary Insomnia,Sleep Initiation Dysfunction,Transient Insomnia,Awakening, Early,Dysfunction, Sleep Initiation,Dysfunctions, Sleep Initiation,Insomnia Disorders,Insomnia, Chronic,Insomnia, Nonorganic,Insomnia, Primary,Insomnia, Psychophysiological,Insomnia, Rebound,Insomnia, Secondary,Insomnia, Transient,Insomnias,Sleep Initiation Dysfunctions
D008297 Male Males
D008874 Midazolam A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH. Dormicum,Midazolam Hydrochloride,Midazolam Maleate,Ro 21-3981,Versed,Hydrochloride, Midazolam,Maleate, Midazolam,Ro 21 3981,Ro 213981
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010076 Oxazepam A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia. Adumbran,Serax,Tazepam
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001569 Benzodiazepines A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Benzodiazepine,Benzodiazepine Compounds

Related Publications

R Lupolover, and U Ballmer, and J Helcl, and J Escher, and B Pavletic
January 1983, British journal of clinical pharmacology,
R Lupolover, and U Ballmer, and J Helcl, and J Escher, and B Pavletic
August 1990, Journal of clinical psychopharmacology,
R Lupolover, and U Ballmer, and J Helcl, and J Escher, and B Pavletic
January 1983, British journal of clinical pharmacology,
R Lupolover, and U Ballmer, and J Helcl, and J Escher, and B Pavletic
January 1983, British journal of clinical pharmacology,
R Lupolover, and U Ballmer, and J Helcl, and J Escher, and B Pavletic
January 1983, British journal of clinical pharmacology,
R Lupolover, and U Ballmer, and J Helcl, and J Escher, and B Pavletic
April 1990, International clinical psychopharmacology,
R Lupolover, and U Ballmer, and J Helcl, and J Escher, and B Pavletic
January 1978, New York state journal of medicine,
R Lupolover, and U Ballmer, and J Helcl, and J Escher, and B Pavletic
April 2000, Forschende Komplementarmedizin und klassische Naturheilkunde = Research in complementary and natural classical medicine,
R Lupolover, and U Ballmer, and J Helcl, and J Escher, and B Pavletic
January 1983, British journal of clinical pharmacology,
R Lupolover, and U Ballmer, and J Helcl, and J Escher, and B Pavletic
January 1983, British journal of clinical pharmacology,
Copied contents to your clipboard!